Lv1
48 积分 2023-01-06 加入
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma
6个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
9个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
11个月前
已完结
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
1年前
已完结
An FDA oncology analysis of antibody-drug conjugates
1年前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
1年前
已完结
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
1年前
已完结
皖公网安备34019202002308
